Security Snapshot

NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) Institutional Ownership

CUSIP: 64130M209

13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

37

Shares (Excl. Options)

12,450,799

Price

$0.76

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, par value, $0.001 per share
Symbol
NMTC on Nasdaq
Shares outstanding
50,013,453
Price per share
$0.78
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
12,450,799
Total reported value
$9,437,810
% of total 13F portfolios
0%
Share change
-1,955,581
Value change
-$1,624,435
Number of holders
37
Price from insider filings
$0.78
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share is tracked under CUSIP 64130M209.
  • 37 institutions reported positions in Q4 2025.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 37 to 2 between Q4 2025 and Q1 2026.
  • Reported value moved from $9,437,810 to $40,500.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 37 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 64130M209?
CUSIP 64130M209 identifies NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MERCHANT ADVENTURE FUND, L.P. 14% $2,478,000 4,200,000 MERCHANT ADVENTURE FUND, L.P. 31 Dec 2024
Bleichroeder LP 8% $2,800,000 4,000,000 Bleichroeder LP 30 Jun 2025
Sio Capital Management, LLC 4.7% -34% $2,098,132 -$1,033,699 2,360,635 -33% Sio Capital Management, LLC 30 Sep 2025
AWM Investment Company, Inc. 4.8% $1,388,959 2,354,167 AWM Investment Company, Inc. 31 Mar 2025
MANCHESTER MANAGEMENT CO LLC 4.9% $934,166 1,583,332 JAMES E. BESSER 31 Dec 2024
LYTTON LAURENCE W 2.6% $764,220 1,295,288 LYTTON LAURENCE W 31 Mar 2025
Nantahala Capital Management, LLC 2.6% $471,270 798,762 Nantahala Capital Management, LLC 30 Sep 2024

As of 31 Dec 2025, 37 institutional investors reported holding 12,450,799 shares of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC). This represents 25% of the company’s total 50,013,453 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) together control 25% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bleichroeder LP 8% 4,000,000 0% 0.53% $3,032,000
BARD ASSOCIATES INC 3.7% 1,846,996 -0.22% 0.36% $1,400,023
VANGUARD GROUP INC 3.2% 1,578,237 0% 0% $1,196,303
PERKINS CAPITAL MANAGEMENT INC 2.9% 1,473,000 +0.34% 0.89% $1,116,534
Sio Capital Management, LLC 2.3% 1,140,040 -52% 0.14% $864,150
RENAISSANCE TECHNOLOGIES LLC 1.5% 763,028 +10% 0% $578,375
GEODE CAPITAL MANAGEMENT, LLC 1% 504,510 +1.5% 0% $382,471
ESSEX INVESTMENT MANAGEMENT CO LLC 0.38% 188,427 0.02% $142,828
Cambridge Investment Research Advisors, Inc. 0.34% 171,000 +41% 0% $130,000
NORTHERN TRUST CORP 0.22% 112,123 0% 0% $84,989
XTX Topco Ltd 0.17% 85,454 +321% 0% $64,774
JANE STREET GROUP, LLC 0.12% 62,312 -42% 0% $47,232
STATE STREET CORP 0.12% 59,499 0% 0% $45,100
MAI Capital Management 0.1% 50,000 0% 0% $37,900
BLAIR WILLIAM & CO/IL 0.1% 48,056 -13% 0% $36,426
Squarepoint Ops LLC 0.1% 47,968 0% $36,360
Legato Capital Management LLC 0.09% 44,329 0% $33,601
CITADEL ADVISORS LLC 0.09% 44,294 -79% 0% $33,575
J.W. COLE ADVISORS, INC. 0.07% 36,000 -3% 0% $27,288
Focus Financial Network, Inc. 0.07% 34,722 0% 0% $26,319
ACADIAN ASSET MANAGEMENT LLC 0.06% 28,135 0% $21,000
GOLDMAN SACHS GROUP INC 0.05% 26,764 0% $20,287
MORGAN STANLEY 0.05% 25,984 +108% 0% $19,696
United Community Bank 0.04% 20,000 0.01% $15,160
Princeton Global Asset Management LLC 0.03% 16,833 0% 0% $12,759

Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 52,156 $40,500 -$2 $0.78 2
2025 Q4 12,450,799 $9,437,810 -$1,624,435 $0.76 37
2025 Q3 14,406,380 $12,801,427 +$798,232 $0.89 34
2025 Q2 13,532,500 $9,178,137 +$7,852,763 $0.68 30
2025 Q1 1,929,327 $1,640,294 +$267,014 $0.85 18
2024 Q4 1,618,518 $1,336,454 -$822,631 $0.83 20
2024 Q3 2,423,467 $2,399,034 -$268,422 $0.99 21
2024 Q2 2,735,360 $2,187,702 -$97,024 $0.80 18
2024 Q1 2,846,820 $3,416,201 -$33,927 $1.20 18
2023 Q4 2,862,898 $4,523,339 +$578,694 $1.58 20
2023 Q3 2,618,184 $2,331,807 +$1,492,764 $0.89 18
2023 Q2 938,623 $1,126,777 -$44,391 $1.20 13
2023 Q1 962,913 $1,549,540 +$453,337 $1.61 14
2022 Q4 722,249 $866,359 +$155,582 $1.20 18
2022 Q3 409,378 $686,000 +$3,717 $1.69 9
2022 Q2 479,839 $394,000 -$269,817 $0.82 8
2022 Q1 707,048 $777,000 -$2,285,922 $1.10 8
2021 Q4 1,946,125 $3,774,000 +$3,070,716 $1.94 12
2021 Q3 250,733 $989,000 -$398,000 $3.94 6
2021 Q2 411,124 $1,522,205 +$1,521,000 $6.63 3